Hepatocellular carcinoma is also called hepatoma or HCC. It's the most common type of primary liver cancer. Because of this, the information in this primary liver cancer section is mostly about ...
The combination of SCD1 inhibitor with standard-of-care oncology agents has the potential of the prevention of drug resistance thus ameliorating the prognosis of patients with hepatoma ...
Here, the authors show that resistance to these drugs is due to Hepatoma up-regulated protein (HURP) competitively binding to the same site on tubulin, countering the drug’s effects. Kinesin ...
New 1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-2-phenylisoquinoline-1(2H)-ones as Phosphoinositide 3-kinase Inhibitors for Treating Cancer and other Diseases.
Hello and welcome to Virtual Investor Conferences. On behalf of OTC Markets and our co-host, Zacks Small-Cap Research, we're very pleased you have joined us for our next live presentation from Genflow ...
[The Relationship between Speed of Platelet Recovery and Its R-squared and Efficacy after First Induction Chemotherapy in Acute Myeloid Leukemia]. [Comparison of Therapeutic Efficacy between ...